CDMO Vetter to establish Shanghai office

The office, located in Puxi, Shanghai, is strategically positioned on Nanjing Road West in the heart of the city’s central business district

Vetter has announced the opening of a business entity in Shanghai, China. The office, the company’s fourth in the Asia Pacific (APAC) region, is intended to increase the visibility of Vetter’s presence in China and underlines its importance to the company.

The office will support customer relations and aid in the development of business. Vetter says China offers a promising injectable pipeline and allows the CDMO to offer support to domestic companies that plan on bringing their molecules to the global market. As a strategic partner, the company supports its customer base through their injectable drug product’s lifecycle, from early development activities to commercial supply up to lifecycle initiatives.

“We are convinced that our continued investment in the Asia Pacific region will significantly contribute to our future global growth,” said Vetter MD Peter Soelkner. “With an increased share of Asian firms among the Top 50 Pharma companies worldwide over the last several years, our mission is to service the needs of our global customer base, of course including Asia, in the best-possible way.”

Oskar Gold, Vetter’s Senior VP for Asia Pacific/Emerging Global Markets said: “Our presence in China demonstrates our dedication in one of the most important markets of the APAC region and will help to increase the awareness of Vetter’s services by presenting our expertise and market position onsite.” The office is staffed by Jason Zhong, who assumes the position of Business Development Manager China. As the first member of the team in China, Zhong will lead Vetter’s business activities reporting to Chervee Ho, who is Vetter’s Director Key Account Management Asia Pacific, based in Singapore.

The office, located in Puxi, Shanghai, is strategically positioned on Nanjing Road West in the heart of the city’s central business district. Its creation follows Vetter’s business development activities in its APAC regional office in Singapore, as well as in its sales offices in Japan and South Korea, further strengthening its footprint in the Asia Pacific region.

Featured Companies

Vetter Pharma International (more information, website)